Randomized Comparison of Endocardial Versus Epicardial - From the Coronary Sinus - Left Ventricular Pacing for Resynchronization in Heart Failure.

NCT ID: NCT01260402

Last Updated: 2022-02-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

6 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-03-03

Study Completion Date

2015-07-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Biventricular pacing is a validated treatment for patients suffering from heart failure resistant to medical treatment. However, up to 30% of the patients are non responsive to this strategy using the coronary sinus approach to pace the Left Ventricle (LV).

It has been demonstrated that the magnitude of the improvement was highly dependant on the LV pacing site. The coronary sinus approach rarely offers more than 1 or 2 potential pacing sites. Resynchronisation using a transeptal approach to pace the left ventricle on the cardiology has been shown feasible on small series. We therefore would like to compare these two approached in a randomised prospective study to confirm the hypotheses that endocardial LV pacing by offering multiple choices for the pacing sites reduces the number of non responders and is associated with greater hemodynamic benefit when compared to the conventional coronary sinus approach.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Failure Cardiomyopathy, Dilated Coronary Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Epicardial

Group Type ACTIVE_COMPARATOR

Resynchronization using a coronary sinus approach

Intervention Type DEVICE

Cardiac resynchronization with one in the right ventricle and one in the left ventricle via the coronary sinus.

Devices used for procedure : RADI PressureWire, routine catheters chosen by operator

Endocardial

Group Type EXPERIMENTAL

Resynchronization using a transeptal approach

Intervention Type DEVICE

Cardiac resynchronization with one in the right ventricle and one in the left ventricle via a transeptal puncture.

Devices used for procedure : Medtronic C304 or 6227DEF, Nykanen RF Wire, RADI PressureWire

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Resynchronization using a transeptal approach

Cardiac resynchronization with one in the right ventricle and one in the left ventricle via a transeptal puncture.

Devices used for procedure : Medtronic C304 or 6227DEF, Nykanen RF Wire, RADI PressureWire

Intervention Type DEVICE

Resynchronization using a coronary sinus approach

Cardiac resynchronization with one in the right ventricle and one in the left ventricle via the coronary sinus.

Devices used for procedure : RADI PressureWire, routine catheters chosen by operator

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult (aged 18 or above)
* Cardiac insufficiency of whatever cause (ischemic or non-ischemic)
* Left ventricular ejection fraction \<35%
* NYHA Class III or IV with optimal medical treatment
* QRS duration \> 120 ms
* Sinus rhythm
* Patient must have signed informed consent
* Patient must be registered in the national health care system

Exclusion Criteria

* Aged under 18
* Patient with a mitral or aortic prosthesis
* Patient with contraindication to anti-coagulants
* Pregnant women
* Participation in another study
* Patient with contraindication for left ventricle catheterization by retrograde aortic approach , as a severe aortic stenosis requiring surgery, or an ascending aorta aneurism
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Bordeaux

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Pierre JAIS, MD

Role: PRINCIPAL_INVESTIGATOR

University Hospital Bordeaux, France

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cardiologic Hospital Haut l'évêque

Pessac, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CHUBX 2010/12

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.